RecruitingNCT05921279

Understanding CARdiac Events in Breast Cancer

Understanding CARdiac Events in Breast Cancer - Pilot Cardio-Oncology Assessment and Surveillance Pathway for Breast Cancer Patients

Sponsor

National University of Ireland, Galway, Ireland

Enrollment

100 participants

Start Date

Jan 14, 2023

Study Type

OBSERVATIONAL

Conditions

Breast Cancer Heart Failure Cardiotoxicity Cardiomyopathies Chemotherapeutic Toxicity Oncology

Summary

In Ireland, over 3,000 patients are diagnosed with breast cancer annually, and 1 in 9 Irish women will be diagnosed with breast cancer in their lifetime. There is evidence that female breast cancer survivors are more likely to die of cardiovascular disease than their age-matched counterparts. This research is focused on evaluating pathways for identifying, managing, and overcoming side effects of cancer therapies that can negatively impact quality-of-life and overall outcomes for women during and after cancer treatment. The Cardio-oncology research team at GUH plan to capitalize on their expertise in both cancer care and cardiology to develop a care pathway for cancer patients who are at increased risk of developing heart disease.

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 90 Years

Plain Language Summary

Simplified for easier understanding

This study (CARE-BC) is looking at changes in heart health in women with early-stage breast cancer who are about to undergo chemotherapy. Chemotherapy can affect the heart, and this study uses heart imaging, blood tests, and other measurements taken over time to better understand who is most at risk and why. The goal is to eventually help doctors identify and prevent heart problems during cancer treatment. **You may be eligible if:** - You are a woman aged 18 or older - You have been diagnosed with stage I, II, or III breast cancer - You are planning to receive chemotherapy with curative intent (to try to cure the cancer) - You can read and understand English **You may NOT be eligible if:** - You are not being treated with chemotherapy aimed at curing your cancer - You are unable to cooperate with the study requirements - You are unable to provide informed consent Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.